TL;DR
This review explores the emerging technique of morcellation during en bloc resection of bladder tumors (ERBT) for larger lesions. By breaking down large tumors into smaller, manageable pieces, morcellation aims to improve specimen retrieval and pathological assessment, potentially leading to better oncological outcomes and reduced need for follow-up procedures.
What Problem Does This Paper Address?
Currently, the standard treatment for non-muscle invasive bladder cancer (NMIBC) is transurethral resection of bladder tumor (TURBT). However, TURBT is typically performed in a piecemeal fashion, which often results in fragmented specimens. This fragmentation makes it difficult for pathologists to accurately assess crucial factors like tumor depth, surgical margins, and the presence of the detrusor muscle (DM). The DM's presence is a key indicator of a complete resection and aids in accurate staging. While "en bloc resection of bladder tumor" (ERBT) has been developed to overcome these limitations by removing tumors in one piece, it has been challenging for larger tumors (over 3 cm) due to difficulties in extracting the entire specimen intact. This paper addresses the challenge of managing large bladder tumors with ERBT by investigating the role and feasibility of using morcellation to facilitate their removal.
Methods
This paper is a narrative review, meaning it synthesizes existing research rather than presenting new experimental data. The authors conducted a comprehensive literature search across multiple databases to identify studies related to morcellation in ERBT for large bladder tumors. They focused on studies reporting on recurrence rates, detrusor muscle presence in specimens, and perioperative complications. Additionally, they surveyed uropathologists to gather their perspectives on how morcellation impacts their ability to assess pathological features like margins, staging, and lymphovascular invasion.
Datasets
Not discussed in the paper. This is a review article, not an empirical study with datasets.
Key Insights and Ideas
- Morcellation as a Solution for Large ERBT Specimens: The core idea is that morcellation can bridge the gap between the benefits of ERBT and the practical challenges of removing large bladder tumors intact.
- Pathologist's Perspective is Crucial: The inclusion of a uropathologist survey highlights the importance of ensuring that the pathological assessment remains robust even with morcellated specimens.
- Potential for Reduced Follow-up: By improving the quality of the initial resection and pathological assessment, morcellation in ERBT might reduce the need for costly and invasive procedures like second-look TURBT.
- Learning Curve and Equipment are Barriers: The adoption of this technique may be hindered by the need for specialized equipment and the surgeon's learning curve.
Key Results
- Facilitates Retrieval: Morcellation has shown potential in facilitating the retrieval of large tumor specimens, making ERBT feasible for tumors larger than 3 cm.
- Maintains Pathological Accuracy: Uropathologists surveyed indicated that morcellation does not significantly impair the assessment of critical factors like detrusor muscle presence, depth of invasion, and lymphovascular invasion. While margin assessment might be more challenging, it's considered less critical for staging.
- Improved Specimen Quality: Morcellated specimens from ERBT, especially those using laser energy, are considered of higher quality due to less thermal damage compared to traditional TURBT.
- Limited Oncological Outcome Data: While promising, there is currently limited evidence specifically on the impact of morcellation in ERBT on oncological outcomes like recurrence and progression for large tumors.
- Learning Curve: Proficiency with morcellation techniques requires experience, with estimates suggesting a learning curve of 30-60 cases for optimal efficiency and safety.
Limitations and Future Work
- Limited Evidence on Oncological Outcomes: The authors acknowledge the significant lack of oncological data specifically addressing the outcomes associated with morcellation in ERBT for large bladder tumors.
- Need for Further Research: Continued research is deemed necessary to establish the oncological safety and efficacy of this approach.
- Specialized Equipment and Learning Curve: The need for specialized equipment and the surgeon's learning curve are identified as potential limitations to widespread adoption.
- Theoretical Advantages: Some of the potential benefits, such as reduced recurrence rates due to minimized tumor cell scattering, are based on theoretical assumptions and require further validation.
- Future Directions: The paper suggests that continued research and technological innovation are crucial for optimizing the implementation of morcellation in ERBT for clinical practice.
Summary updated